A recent study investigating immune evasion mechanisms by genome-scale in vivo CRISPR screens across cancer models treated with ICB (89) identified immune evasion genes and immunosuppressive checkpoints conserved across cancers, including the non-classical MHC class I molecule Qa-1b/HLA-E. Here, HLA-E is linked to cancer.